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dependent apical excretion of p-aminohippurate andThis session was opened by Gerhard Burckhardt
probably also of other organic anions [5]. In summary,(Go¨ttingen, Germany). He summarized “the role of or-
OATs are involved in renal drug excretion and play anganic anion transporters (OATs) in the uptake of drugs
important role in the pharmacokinetics and nephrotoxic-into renal cells” [1]. OAT1 (SLC22A6) is located at the
ity of renally eliminated drugs.basolateral membrane of S2 proximal tubule epithelial
Ernst Petzinger (Giessen, Germany) summarized thecells of rat and human kidney. It exchanges intracellu-
current knowledge of the second family or superfamilylar -ketoglutarate against extracellular organic anions,
of organic anion transporters, namely the so-called “or-thereby driving organic anion uptake against the prevail-
ganic anion transporting polypeptides [rodents: Oatpsing electrochemical potential difference. In flounder re-
(Slc21a); humans OATPs (SLC21A)].” Oatps/OATPsnal OAT1, two positively charged, conserved amino
were first cloned from rat and human liver, where theyacids (K394 and R478) have been identified to be essen-
mediate sodium-independent basolateral (sinusoidal)tial for interaction with dicarboxylates. In all species
uptake of a large variety of amphipathic, albumin-boundOAT1 exhibits a broad substrate specificity and is re-
organic anions including bile salts, bromosulfophthalein,sponsible for uptake of most amphiphilic organic anions
steroid-conjugates, thyroid hormones, drugs (such as car-into proximal tubule cells. Besides classical organic anions,
diac glycosides, ACE-inhibitors, HMG-CoA reductasefor example, p-aminohippurate, its substrate spectrum
inhibitors), oligopeptides and natural hepatotoxins (forincludes numerous drugs (such as, -lactam antibiotics,
example, phalloidin, ochratoxin A, microcystin) [6]. Mean-antiviral drugs), nephrotoxins (such as, ochratoxin A)
while at least 11 rat, 8 mouse and 9 human Oatps/OATPsand heavy metal chelators [for example, 2,3-dimercapto-
have been identified and shown to be expressed, to vary-propane-1-sulfonate (DMPS)] [2, 3]. Closely related to
ing degrees, in multiple tissues including liver (rat Oatp1,OAT1 is OAT3 (SLC22A8), which exhibits a similar
rOatp2, rOatp4, hOATP-B, hOATP-C, hOATP8), intes-localization and similar polyspecific substrate transport
properties as OAT1. However, OAT3 cannot exchange tine (rOatp3), blood-brain barrier (rOatp2, hOATP-A),
choroid plexus (rOatp1/3, rOatp2), retina (rOatp2), pla-intracellular -ketoglutarate for extracellular organic
anions. OAT2 (SLC22a7) and OAT4 are more distantly centa (hOATP-B) and testis (hOATP-F) [6–10]. The
Petzinger group has identified four new Oatp-homologsrelated to OAT1/OAT3. Although OAT2 and OAT4
are polyspecific transporters, they cannot mediate -keto- in the cattle that show high amino acid sequence identi-
ties with the human OATPs. Especially, three cattleglutarate/organic anion exchange. OAT2 is expressed in
the liver and also in the kidneys of female rats [4]. OAT4 Oatps were identified in the adrenal glands, where they
are supposed to mediate high affinity transport of themay be localized at the apical membrane of human renal
proximal tubule cells and may be involved in the excre- cardiac glycoside ouabain, which might represent an en-
dogenous “digitalis-like factor” synthesized within adre-tion of organic anions into the urine. However, the multi-
drug resistance protein Mrp2 is responsible for ATP- nal glands of animals and man. Hence, Oatps/OATPs
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might be involved in high affinity transport of endoge- At the canalicular plasma membrane monoquaternary
drugs (for example, N-methyl-quinidine, N-methyl-qui-nous compounds in selected tissues in addition to their
nine) are transported in a stereospecific manner by ratrole in overall amphipathic drug clearance by the liver
Mdr1b and human MDR1, but not by Mdr2 [12].and other drug eliminating organs. Since the Oatps/
OATPs can remove amphipathic drugs from their albu-
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at the level of intestine, liver and kidney. On the otherThe last session was opened by Martin Fromm (Stutt-
hand, the antibiotic rifampicin enhances P-glycoproteingart, Germany), who talked about “ABC transporters and
(P-gp) expression and causes reduced plasma concentra-drug disposition.” Clinically important are, for example,
tions of P-gp substrates. In addition, a widespread C3435Tdrug-drug interactions such as the enhancement of blood
mutation of P-gp has been shown to be associated withconcentrations of the heart glycoside digoxin during con-
low level P-gp expression in gut and higher bioavailabilitycomitant treatment with the anti-arrhythmic drug quinidine
of digoxin in Caucasians [2].[1]. The underlying mechanism is inhibition of P-glycopro-
tein mediated digoxin transport, which occurs most likely Alfred Schinkel (Amsterdam, The Netherlands)
